CF33-hNIS-antiPDL1. *moves mouse to x button to close tab* “But wait!” your writer screams from the page, “I promise it's…
Since securing a European patent for their proprietary cancer vaccine HER-Vaxx, Imugene (ASX: IMU) have been busy. The Company has…
Cancer treatment is slowly shifting away from the standard chemo and radiation and more towards immunotherapy as an alternative treatment.…
Despite the many advances in cancer therapy, we still haven’t quite hit the nail on the head, with cancer still…
Biopharma company Imugene (ASX: IMU) is now on their way towards commercialisation of their lung cancer treatment with approval from…